Omri Drory

Omri Drory shows some public alignment with radical longevity and names a broad strategic frame of reprogramming, regeneration, and replacement. However, the evidence is thin: most items are reposts, there are no destination quotes, timelines, risk framing, or detailed public theory of change, and only one direct path statement is available.

No citation metrics, authored papers, most-cited works, clinical trials, or independent evidence of scientific contributions are provided. The evidence only shows self-published or reposted interest in techbio/longevity and a claimed role as an NFX GP and Renewal Bio founder, which is insufficient to establish direct or enabled scientific impact.

Capital deployment is applicable because Drory presents himself as a techbio-focused GP and founder, but the provided evidence contains no disclosed longevity investments, donations, allocation amounts, or independently corroborated deployment. The strongest signals are self-published claims of institutional roles and longevity interest, which support only a low score.

The evidence shows a coherent strategic thesis around high-risk techbio infrastructure and radical longevity themes, especially measurement, reprogramming, regeneration, and replacement. However, the record provided is mostly self-published profile text and reposts, with no disclosed investments, donations, company outcomes, timing, or clear counterfactual evidence that his choices opened paths others missed. This supports some strategic taste signal, but not a high score.

The dimension applies, but the provided evidence shows only weak, self-published signals of field-building. Omri Drory's X profile claims he is founder of Renewal Bio and an investor focused on techbio, and one post references a '3 R’s of radical longevity' framing, but there is no primary or independent corroboration that he created organizations, programs, funding paths, protocols, or communities that materially made longevity work more legible or possible for others. Structured facts explicitly found no founded organizations or donation-created programs.

There is limited evidence of public conviction: Drory publicly used and endorsed a specific 'radical longevity' framing around reprogramming, regeneration, and replacement. However, the evidence is recent, sparse, mostly repost-based, and does not show meaningful downside, sustained criticism, self-experimentation, or a large personal/professional bet relative to capacity.

The dimension applies, but the evidence only shows self-published positioning and amplification of techbio/longevity themes, not independently corroborated second-order leverage such as attracting founders, capital, collaborators, policy attention, or follow-on projects. His claimed NFX techbio role suggests possible leverage, but the provided evidence does not document achieved multiplier effects.